Cyanogen Bromide → 5-(5-amino-[1,3,4]oxadiazol-2-yl)-4-(4-bromo-2-fluorophenylamino)-3-fluoro-1-methyl-1H-pyridin-2-one
Reaction equation
[N:1]#[C:2]Br.[Br:4][C:5]1[CH:10]=[CH:9][C:8]([NH:11][C:12]2[C:13]([C:21]([NH:23][NH2:24])=[O:22])=[CH:14][N:15]([CH3:20])[C:16](=[O:19])[C:17]=2[F:18])=[C:7]([F:25])[CH:6]=1.C([O-])(O)=O.[Na+]>O1CCOCC1.O>[NH2:1][C:2]1[O:22][C:21]([C:13]2[C:12]([NH:11][C:8]3[CH:9]=[CH:10][C:5]([Br:4])=[CH:6][C:7]=3[F:25])=[C:17]([F:18])[C:16](=[O:19])[N:15]([CH3:20])[CH:14]=2)=[N:23][N:24]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
Cyanogen bromide (36 mg, 0.31 mmol) was added to a suspension of 4-(4-bromo-2-fluorophenylamino)-5-fluoro-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid hydrazide (63 mg, 0.169 mmol) in dioxane (2 mL) followed by an aqueous NaHCO3 (2 mL of a 0.09 M solution) solution. After 17 hours, additional cyanogen bromide (14 mg) was added. After 19; hours, the reaction mixture was diluted with water and extracted with ethyl acetate. The combined organic extracts were washed with brine, dried (MgSO4) and concentrated under reduced pressure. Crystallization (MeOH:THF) followed by trituration (Et2O:MeOH 5:1) gave clean desired product as a white solid (60 mg, 89%). MS APCI (+) m/z 398, 400 (M+, Br pattern) detected; 1H NMR (400 mHz, CD3OD) δ 8.06 (s, 1H), 7.37 (d, 1H), 7.31 (d, 1H), 7.10 (td, 1H), 3.64 (s, 3H).
Workup
- extractionextracted with ethyl acetate
- washThe combined organic extracts were washed with brine
- dry with materialdried (MgSO4)
- concentrationconcentrated under reduced pressure
- customCrystallization (MeOH:THF)
Sources & evidence
- ORD record
- ord-82eb95566f2d4ee1be4d738819b866a2
- Source dataset
- uspto-grants-2012_07
- Patent number
- US08211920B2
Reaction notes
Loading…